CBDMB

(Synonyms: 5-N-(4-Chlorobenzyl)-2',4'-dimethylbenzamil)

CBDMB (5-N-(4-Chlorobenzyl)-2',4'-dimethylbenzamil) is a Na+/Ca2+ exchanger inhibitor. CBDMB blocks both forward and reverse transport and preferentially inhibits Ca2+ influx by interacting with the intracellular Na+ site. CBDMB enhances glutamate-induced neurotoxicity and delayed neuronal death. CBDMB reduces procoagulant platelet responses, Annexin V-positive phosphatidylserine-exposing platelets, and COAT formation by inhibiting reverse-mode NCX, and delays the loss of mitochondrial membrane potential and superoxide production. CBDMB can be used for research on focal cerebral ischemia.

For research use only. We do not sell to patients.

  • CAS No.: 118573-60-7
  • Formula: C22H23Cl2N7O
  • Molecular Weight:472.37
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00